Dabigatran Impurity 52 | CAS 1456355-39-7 - Request Quote
Dabigatran Impurity 52
| SZ CAT No: | SZ-D012133 |
| CAS No | 1456355-39-7 |
| Mol.F. | C13H12N4O3 |
| Mol.Wt. | 272.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabigatran Impurity 52 is chemically 4-(Methylamino)-3-nitro-N-(pyridin-2-yl)benzamide. Dabigatran Impurity 52 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 52 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1456355-39-7
Purchase 1456355-39-7
Order 1456355-39-7
Enquire 1456355-39-7
price of 1456355-39-7
1456355-39-7 Supplier
1456355-39-7 Manufacturer
1456355-39-7 Exporter
buy high quality Dabigatran Impurity 52
Purchase Dabigatran Impurity 52
Dabigatran Impurity 52 suppliers
Dabigatran Impurity 52 manufacturers
Dabigatran Impurity 52 price
Order Dabigatran Impurity 52
Enquire Dabigatran Impurity 52
Dabigatran Impurity 52 cost
Dabigatran Impurity 52 Supplier
Dabigatran Impurity 52 Distributor
Dabigatran Impurity 52 for Method Validation
Dabigatran Reference Standard
Dabigatran Impurity 52 for ANDA Filing
Dabigatran Impurity 52 for Forced Degradation Studies
Dabigatran Impurity 52 Identification Standards
Dabigatran Impurity 52 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.